Angiodynamics (ANGO) Short term Debt (2011 - 2025)

Angiodynamics has reported Short term Debt for 14 years, with the latest figure at $5.0 million in Q1 2025.

• For the quarter ending Q1 2025, Short term Debt fell 47.37% year-over-year to $5.0 million; the trailing twelve-month figure through Feb 2025 stood at $5.0 million (down 47.37% YoY), and the FY2024 full-year result was $4.7 million, down 67.97% from the prior year.
• Short term Debt for Q1 2025 stood at $5.0 million, up from $5.0 million in the prior quarter.
• The five-year high for Short term Debt was $14.8 million in Q2 2023, with the low at $4.7 million in Q2 2024.
• Historically, Short term Debt has averaged $7.9 million across 4 years, with a median of $8.8 million in 2022.
• Annual changes were most pronounced in 2023 — Short term Debt surged 68.06% — and 2024, when it slumped 67.97%.
• Angiodynamics' Short term Debt stood at $9.8 million in 2022, then dropped by 3.82% to $9.4 million in 2023, then plunged by 47.16% to $5.0 million in 2024, then grew by 0.81% to $5.0 million in 2025.
• The last three Short term Debt figures came in at $5.0 million (Q1 2025), $5.0 million (Q4 2024), and $4.8 million (Q3 2024), per Business Quant data.